Ender Soydan
Overview
Explore the profile of Ender Soydan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
190
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Acar R, Paydas S, Yildirim M, Kilicarslan E, Sahin U, Dogan A, et al.
J Cancer Res Ther
. 2023 May;
19(Supplement):S138-S144.
PMID: 37147993
Introduction And Aim: Primary mediastinal B-cell lymphomas (PMBL) are aggressive B- cell lymphomas. Although the initial treatment models vary in PMBL, appropriate treatment methods are not known. We aim to...
2.
Sahin U, Gokmen A, Soydan E, Urlu S, Merter M, Gokgoz Z, et al.
Clin Lymphoma Myeloma Leuk
. 2022 Nov;
23(1):e1-e13.
PMID: 36344419
Introduction: Standard consolidation for primary diffuse large B cell lymphoma (DLBCL) of the central nervous system (CNS) (PCNSL) is not established. This single center, retrospective observational study aims to define...
3.
Gokmen A, Sahin U, Soydan E, Gokgoz Z, Okcu M, Ozan U, et al.
Clin Lymphoma Myeloma Leuk
. 2022 Aug;
22(10):e885-e892.
PMID: 35927182
Background: Second line salvage chemotherapy followed by autologous stem cell transplantation (ASCT) is the current standard treatment for eligible patients with relapsed and refractory (R/R) Hodgkin lymphoma (HL). Several salvage...
4.
Sahin U, Soydan E, Gokmen A, Ozcan M, Arslan O
Bone Marrow Transplant
. 2020 Aug;
56(1):7-8.
PMID: 32848191
No abstract available.
5.
Altun R, Gokmen A, Tek I, Soydan E, Kurt Yuksel M
Turk J Gastroenterol
. 2016 Jul;
27(4):312-6.
PMID: 27458845
Background/aims: Acute graft-versus-host disease (GVHD) is a common complication of haematopoietic cell transplantation (HCT), with the gastrointestinal tract (GIT) as one of the main target organs. There is a lack...
6.
Arslan O, Coskun H, Arat M, Soydan E, Ozcan M, Gurman G, et al.
Turk J Haematol
. 2016 Jun;
19(3):401-9.
PMID: 27264977
ABO incompatibility is not a contraindication for allogeneic bone marrow transplantation, but this procedure requires an extra effort for erythrocyte or plasma depletion in certain well established conditions. Some acute...
7.
Sanli H, Akay B, Soydan E, Kocyigit P, Arat M, Ilhan O
Turk J Haematol
. 2016 Jun;
27(2):91-8.
PMID: 27263450
Objective: We aimed to evaluate the clinical features of sclerodermatous chronic graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (AHSCT). Methods: We retrospectively analyzed 423 patients who underwent AHSCT....
8.
Gorgun G, Calabrese E, Soydan E, Hideshima T, Perrone G, Bandi M, et al.
Blood
. 2010 Jul;
116(17):3227-37.
PMID: 20651070
The bone marrow (BM) microenvironment consists of extracellular-matrix and the cellular compartment including immune cells. Multiple myeloma (MM) cell and BM accessory cell interaction promotes MM survival via both cell-cell...
9.
Tai Y, Soydan E, Song W, Fulciniti M, Kim K, Hong F, et al.
Blood
. 2009 Feb;
113(18):4309-18.
PMID: 19196658
CS1 is highly expressed on tumor cells from the majority of multiple myeloma (MM) patients regardless of cytogenetic abnormalities or response to current treatments. Furthermore, CS1 is detected in MM...
10.
Yazman D, Konuk N, Ozcan M, Arat M, Soydan E, Arslan O, et al.
Ther Apher Dial
. 2008 May;
12(3):255-8.
PMID: 18503705
Therapy in refractory chronic idiopathic thrombocytopenic purpura is usually a difficult and expensive procedure, with little benefit to the patient, and the results are typically only short-term improvements. In this...